Lynne Kaminer to Maintenance Chemotherapy
This is a "connection" page, showing publications Lynne Kaminer has written about Maintenance Chemotherapy.
Connection Strength
0.201
-
Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial. Leuk Res. 2021 12; 111:106736.
Score: 0.201